New Technology from Asymmetrex Promises to End the Era of "Elusive"...

This week an accepted-ahead-of-print report published online in the journal Stem Cell Research describes the development of a new technology from the stem cell technology start-up Asymmetrex that promises to move stem cell biology and biomedicine into a new quantitative era. Two commercially available antibodies can be used to specifically identify adult tissue stem cells for the first time.

http://ift.tt/1xU4M2z